IL6 and Cachexia: We next treated ApcMin/+ mice exhibiting initial body weight loss with an IL-6 receptor antibody for two weeks to block systemic IL-6 signaling including both classical and trans IL-6 signaling (Rose-John, 2012), during a pivotal time point in the progression of cachexia.